A dual-readout PCR–LbCas12a protocol for mutation-selective detection of the m.3243A>G variant in peripheral blood-derived DNA
Mitochondrial Communications · 2026 · 4 · 59-67
DOI: 10.1016/j.mitoco.2026.10.002 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Mitochondrial Communications, 2026. Verfasst von Yu Shen und 6 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The pathogenic m.3243A > G mitochondrial DNA (mtDNA) variant displays variable heteroplasmy and a wide range of multisystem clinical phenotypes. Peripheral blood DNA serves as a readily accessible matrix for the selective detection of this mutation.
Methods
We established a dual-readout PCR assay based on Lachnospiraceae bacterium Cas12a (LbCas12a), employing an 18-nt spacer crRNA targeting m.3243G, together with ROX–BHQ2 fluorescent and FAM–biotin lateral-flow reporters. Assay performance was validated using synthetic wild-type and mutant DNA duplexes with predefined heteroplasmy fractions. Forty-two clinical peripheral blood DNA samples, including 10 m.3243A > G-negative controls and 32 m.3243A > G-positive specimens, were tested. Readouts from fluorescence and lateral flow were compared against heteroplasmy values determined by bidirectional Sanger sequencing and Minor Variant Finder (MVF) analysis using identical primers. ROC analysis and nonparametric bootstrap were applied to evaluate diagnostic performance.
Results
Synthetic templates confirmed mutation-specific activation of LbCas12a. A 40-min fluorescence endpoint was selected to enhance the visualization of low heteroplasmy fractions, with a strong linear correlation between fluorescence signal and input mutant fraction (r = 0.948). In clinical samples, fluorescence radiant efficiency and lateral-flow test-to-control (T/C) ratios were positively correlated with Sanger/MVF heteroplasmy estimates (r = 0.856 and 0.715, respectively; both p G and heteroplasmy-related signal profiling in peripheral blood-derived DNA.
Zitieren
APA
Shen, Y., Yang, S., Zhang, Z., He, X., Peng, P., Du, Y., & Ji, D. (2026). A dual-readout PCR–LbCas12a protocol for mutation-selective detection of the m.3243A>G variant in peripheral blood-derived DNA. Mitochondrial Communications, 4, 59-67. https://doi.org/10.1016/j.mitoco.2026.10.002
Vancouver
Shen Y, Yang S, Zhang Z, He X, Peng P, Du Y, et al. A dual-readout PCR–LbCas12a protocol for mutation-selective detection of the m.3243A>G variant in peripheral blood-derived DNA. Mitochondrial Communications. 2026;4:59-67. doi:10.1016/j.mitoco.2026.10.002
BibTeX
@article{Shen2026,
author = {Shen, Yu and Yang, Shaoyu and Zhang, Zhikang and He, Xinyao and Peng, Pai and Du, Yi and Ji, Dongmei},
title = {A dual-readout PCR–LbCas12a protocol for mutation-selective detection of the m.3243A>G variant in peripheral blood-derived DNA},
journal = {Mitochondrial Communications},
year = {2026},
volume = {4},
pages = {59--67},
doi = {10.1016/j.mitoco.2026.10.002}
}
EUVIMED